Zacks Investment Research on MSN
Investors heavily search UiPath, Inc. (PATH): Here is what you need to know
UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
UiPath is giving enterprises more ways to coordinate AI agents, robots, and people, with the next readout focused on whether ...
UiPath Inc. (NYSE:PATH) is one of the best AI software stocks to buy according to hedge funds. UiPath Inc. (NYSE:PATH) ...
Zacks Investment Research on MSN
UiPath's agentic AI adoption continues to gain momentum
UiPath PATH is making meaningful progress in one of the most important areas of enterprise software today: agentic AI ...
UiPath (PATH) stock analysis: accelerating revenue and ARR near $2B with strong margins. Read the full analysis here.
The company saw its revenue and ARR accelerate, but it issued cautious guidance.
PATH is growing its base of high-value customers, signaling deeper enterprise adoption of its automation and AI platform.
UiPath (NYSE: PATH) isn't just an automation company anymore. It's quietly transforming into a key infrastructure player at the intersection of automation, data, and artificial intelligence (AI). To ...
Healthcare leaders are realising that automating isolated tasks isn't enough to stay afloat. See how the UiPath Business ...
Trupeer AI appoints former UiPath CEO Raghu Subramanian to drive commercial expansion and enterprise adoption of its AI video ...
UiPath will reduce roughly 5% of its total workforce as part of the company's restructuring plan, according to a recent SEC filing. The company said that it had 4,200 employees as of April 30, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results